UsFda

Aurobindo Pharma Faces Significant Regulatory Hurdle as USFDA Flags Telangana Facility as 'Official Action Indicated'

Wockhardt's Game-Changer: India's First Homegrown NCE Accepted by USFDA – A New Dawn?

A New Chapter for Wockhardt? Chairman 'Very Confident' on Novel Antibiotic's USFDA Acceptance

The Shadow Over the Pharma Giants: When Global Watchdogs Bark

The Looming Storm: How Trade Tensions Could Reshape the World's Pharmacy

India's New Weapon Against Superbugs: Wockhardt's Zaynich Offers Hope in Global AMR Crisis

Lupin's Pithampur Unit 2 Under Scrutiny: USFDA Issues Form 483 with Four Key Observations

Wockhardt Seeks USFDA Nod for Revolutionary Antibiotic Zaynich: A New Hope Against Superbugs

Indian Pharma's Unwavering Allure: Why Mutual Funds Are Doubling Down Amidst Global Headwinds

Major Setback: Indian Pharma Giants Recall Thousands of Drug Batches in US Over Manufacturing Flaws

Lupin Achieves Major Milestone: USFDA Grants Tentative Approval for Generic HIV Treatment Drug

Aurobindo Pharma Under the Microscope: 8 USFDA Observations Rock Shares

Divi's Labs Soars as Jefferies Upgrades to 'Buy' Amid Strong Outlook and Q4 Performance

US FDA Flags Indian Cookware Over Lead Contamination: A Critical Alert for Consumer Safety